RC
ELOS

RBF Capital’s Syneron Medical Ltd ELOS Stock Holding History

RBF Capital’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-18,700
Closed -$161K – 390
2016
Q4 		$161K Hold
18,700
– – 0.02% 320
2016
Q3 		$134K Hold
18,700
– – 0.02% 319
2016
Q2 		$144K Hold
18,700
– – 0.03% 314
2016
Q1 		$137K Buy
+18,700
New +$134K 0.03% 316
2015
Q2 		– Sell
-12,997
Closed -$161K – 342
2015
Q1 		$161K Buy
12,997
+2,339
+22% +$25.9K 0.03% 261
2014
Q4 		$99K Buy
+10,658
New +$103K 0.02% 274

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RBF Capital's ELOS Position: Q1 2017 in Review

RBF Capital sold out of Syneron Medical Ltd (ELOS) in Q1 2017, closing a stake of 18,700 shares — an estimated $161K sold.

RBF Capital first reported a position in ELOS in Q4 2014 and held it in 6 quarters. The position peaked at $161K in Q4 2016. 91 funds tracked by Wall St. Rank hold ELOS as of Q1 2017.

  • RBF Capital reported no remaining Syneron Medical Ltd position as of Q1 2017 after selling out during the quarter.
  • RBF Capital sold 18,700 Syneron Medical Ltd shares in Q1 2017, an estimated $161K.
  • RBF Capital first reported a position in Syneron Medical Ltd in Q4 2014 and held it in 6 quarters.
  • RBF Capital's Syneron Medical Ltd position peaked at $161K in Q4 2016.
  • 91 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q1 2017.

Based on RBF Capital's 13F filing for Q1 2017, filed 15 May 2017.